ETON — Eton Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.43bn
- $1.43bn
- $79.95m
Brief: Eton Pharmaceuticals Announces Acquisition Of Pku Golike® For Phenylketonuria
Eton Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Eton Pharmaceuticals Q4 Net Income USD -2.256 Million
Eton Pharmaceuticals Inc expected to post a loss of 4 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Nvidia, Global Payments
U.S. STOCKS ON THE MOVE-Toll Brothers, Natgas firms, Eton Pharmaceuticals
Eton climbs on receiving US patent for oral steroid medicine formulation
Brief: Eton Pharmaceuticals Awarded U.S. Patent For Proprietary Hydrocortisone Oral Liquid Formulation
Brief: Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
Eton rises on commercial availability of its metabolic disorder treatment
Brief: Eton Pharmaceuticals Q3 Net Income USD -579 Thousand
Brief: Eton Pharmaceuticals Under Deal Terms Paid Seller $0.15 mln For Acquisition And Assumed $0.5 mln Of Cure Amounts Owed To Manufacturer
Brief: Eton Pharmaceuticals Announces Acquisition Of FDA-Approved Ultra-Rare Disease Product Nitisinone
U.S. STOCKS ON THE MOVE-Amylyx Pharma, Bakkt, Aptiv
U.S. STOCKS ON THE MOVE-Occidental, Illumina, Walmart
U.S. STOCKS ON THE MOVE-Plus Therapeutics, New Gold
U.S. STOCKS ON THE MOVE-Eton Pharma, Pagaya, Semler Scientific
Eton Pharma rises after upbeat Q2 results
Eton Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary